REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Aug 19, 2026 8-K
4 Aug 18, 2026 4
4 Aug 18, 2026 4
4 Aug 18, 2026 4
4 Aug 18, 2026 4
4 Aug 18, 2026 4
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 6, 2026 8-K
10-Q Aug 6, 2026 10-Q
8-A12B Jul 13, 2026 8-A12B
8-K Jul 13, 2026 8-K
8-K Jun 24, 2026 8-K
8-K Jun 1, 2026 8-K
SCHEDULE 13G May 15, 2026
DEF 14A May 11, 2026 DEF 14A
ARS May 11, 2026 ARS
8-K May 7, 2026 8-K
10-Q May 7, 2026 10-Q
4 May 1, 2026 4
4 May 1, 2026 4
PRE 14A Apr 30, 2026 PRE 14A
S-8 Apr 15, 2026 S-8
8-K Mar 19, 2026 8-K
8-K Feb 26, 2026 8-K
10-K Feb 26, 2026 10-K
← Newer Page 1 of 16 · 387 filings Older →